EudraVigilance (EV)




What is ICH?

The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry of Europe, Japan and the US to discuss scientific and technical aspects of drug registration.

The purpose is to make recommendations on ways to achieve greater harmonisation in the interpretation and application of technical guidelines and requirements for product registration, in order to reduce or obviate the need to duplicate the testing carried out during the research and development of new medicines. The objective of such harmonisation is a more economical use of human, animal and material resources, and the elimination of unnecessary delay in the global development and availability of new medicines whilst maintaining safeguards on quality, safety and efficacy, and regulatory obligations to protect public health.

For more information regarding ICH, the parties involved, the process and the ongoing activities visit:

The ICH Secretariat can also be contacted on:
Tel: 41 (22) 338 32 06

up | go back
Last update: Wednesday, 21 June 2006.



Help Desk


E-Reporting to Member States

Link to EMEA website Link to the EU Commission website